Comparative effectiveness of natalizumab and anti-CD20 monoclonal antibodies in relapsing-remitting multiple sclerosis: a real-world propensity-score matched study

Bassem Yamout, Raed Alroughani, Samar Frouk Ahmed Mohamed, Akram M Al-Mahdawi, Samia Joseph Khoury, Nabil El Ayoubi, Jihad Inshasi, Jabir Alkhaboori, Abdullah Al-Asmi, Riadh Gouider, Salman Aljarallah, Nuha Alkhawajah, Yaser Al Malik, Ahmad Abulaban, Seraj Makkawi, Osama Khojah, Taghrid El-Hajj, Joelle Massouh, Husam AlSalamat, Hani Dimassi, Amal Al-Hajje, Pascale Salameh, Farid Boumediene, Maya Zeineddine

Open source

DOI: 10.1136/jnnp-2024-335704
Published: 2025-06-01
Container: Journal of Neurology, Neurosurgery & Psychiatry
Publisher: BMJ
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/jnnp-2024-335704,
  title = {Comparative effectiveness of natalizumab and anti-CD20 monoclonal antibodies in relapsing-remitting multiple sclerosis: a real-world propensity-score matched study},
  author = {Bassem Yamout and Raed Alroughani and Samar Frouk Ahmed Mohamed and Akram M Al-Mahdawi and Samia Joseph Khoury and Nabil El Ayoubi and Jihad Inshasi and Jabir Alkhaboori and Abdullah Al-Asmi and Riadh Gouider and Salman Aljarallah and Nuha Alkhawajah and Yaser Al Malik and Ahmad Abulaban and Seraj Makkawi and Osama Khojah and Taghrid El-Hajj and Joelle Massouh and Husam AlSalamat and Hani Dimassi and Amal Al-Hajje and Pascale Salameh and Farid Boumediene and Maya Zeineddine},
  year = {2025},
  journal = {Journal of Neurology, Neurosurgery \&amp; Psychiatry},
  doi = {10.1136/jnnp-2024-335704},
  url = {https://doi.org/10.1136/jnnp-2024-335704}
}

RIS

TY  - JOUR
TI  - Comparative effectiveness of natalizumab and anti-CD20 monoclonal antibodies in relapsing-remitting multiple sclerosis: a real-world propensity-score matched study
AU  - Bassem Yamout
AU  - Raed Alroughani
AU  - Samar Frouk Ahmed Mohamed
AU  - Akram M Al-Mahdawi
AU  - Samia Joseph Khoury
AU  - Nabil El Ayoubi
AU  - Jihad Inshasi
AU  - Jabir Alkhaboori
AU  - Abdullah Al-Asmi
AU  - Riadh Gouider
AU  - Salman Aljarallah
AU  - Nuha Alkhawajah
AU  - Yaser Al Malik
AU  - Ahmad Abulaban
AU  - Seraj Makkawi
AU  - Osama Khojah
AU  - Taghrid El-Hajj
AU  - Joelle Massouh
AU  - Husam AlSalamat
AU  - Hani Dimassi
AU  - Amal Al-Hajje
AU  - Pascale Salameh
AU  - Farid Boumediene
AU  - Maya Zeineddine
PY  - 2025
JO  - Journal of Neurology, Neurosurgery &amp; Psychiatry
DO  - 10.1136/jnnp-2024-335704
UR  - https://doi.org/10.1136/jnnp-2024-335704
ER  -

APA

Yamout, B., Alroughani, R., Mohamed, S. F. A., Al-Mahdawi, A. M., Khoury, S. J., Ayoubi, N. E., Inshasi, J., Alkhaboori, J., Al-Asmi, A., Gouider, R., Aljarallah, S., Alkhawajah, N., Malik, Y. A., Abulaban, A., Makkawi, S., Khojah, O., El-Hajj, T., Massouh, J., AlSalamat, H., Dimassi, H., Al-Hajje, A., Salameh, P., Boumediene, F., & Zeineddine, M. (2025). Comparative effectiveness of natalizumab and anti-CD20 monoclonal antibodies in relapsing-remitting multiple sclerosis: a real-world propensity-score matched study. Journal of Neurology, Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2024-335704

Source records

crossref · retrieved 2026-09-26T14:32:16.835Z